Joint International Calls

This scheme is currently closed.

Key Dates 

• JPIAMR opens the call: 10 January 2024
• Webinar for applicants: 24 January 2024
• Preproposals close with JPIAMR: 14 March 2024
• Invited full proposals close with JPIAMR: 9 July 2024
• Applications for NHMRC funding close on Sapphire: 11 July 2024

The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) will launch in 2024 an international call on Interventions moving forward to promote action to counteract the emergence and spread of bacterial and fungal resistance and to improve treatments. This call is intended to create and reinforce the collaboration between research partners coming from different countries and different fields of expertise to promote interventional research on antimicrobial resistance.

The NHMRC intends to invite Australian researchers who are listed on successful preproposals to apply for NHMRC support of the Australian component of the research under the following topics:

• Topic 1: Design novel or improved interventions to prevent, mitigate and /or treat fungal infections, which are resistant to treatments and/or are at risk of developing resistance.
• Topic 2: Improve and/or, compare and/or evaluate strategies, technologies, treatments, methods, protocols or data collection based on existing interventions, aiming to prevent or reduce the emergence or spread of antibacterial or antifungal resistance or to treat/cure infections caused by resistant bacteria/fungi and recommend new policies.

Key Documents

NHMRC

NHMRC documentation is not yet available, but some information is provided in the Forecast Opportunity on GrantConnect

JPIAMR

Further information is available on the JPIAMR website.

The Major Initiatives team is keen to support teams to develop bids with their European colleagues. Please contact us at majorinitiatives@research.uq.edu.au if you would like to explore this opportunity further.

This scheme is currently closed. 

The NHMRC-EU Collaborative Research Grant Scheme supports Australian participation in international collaborative research under Horizon Europe. Horizon Europe facilitates collaboration and strengthens research impact and innovation while tackling global challenges.

Projects involving Australian-based researchers chosen by the EU for funding may be eligible for NHMRC support.

NHMRC will invite Australian researchers who are listed on eligible applications deemed fundable by the European Commission (EC) to apply to NHMRC for support of the Australian component of research under the following topics submitted through the two-stage deadline model:

• HORIZON-HLTH-2024-STAYHLTH-01-05-two-stage: Personalised prevention of noncommunicable diseases- addressing areas of unmet need using multiple data sources
• HORIZON-HLTH-2024-ENVHLTH-02-06-two-stage: The role of environmental pollution in noncommunicable diseases: air, noise, and light, and hazardous waste pollution
• HORIZON-HLTH-2024-DISEASE-03-08-two-stage: Comparative effectiveness research for healthcare interventions in areas of high public health need
• HORIZON-HLTH-2024-DISEASE-03-11-two-stage: Pandemic preparedness and response: Adaptive platform trials for pandemic preparedness; 

and submitted through the single-stage deadline model:

• HORIZON-HLTH-2024-DISEASE-08-20: Pandemic preparedness and response: Host pathogen interactions for infectious diseases with epidemic potential

NHMRC cannot support applications submitted under other Horizon Europe topics that are not listed above.

Projects involving Australian researchers based in Australia that are chosen by the European Commission (EC) for funding, may be eligible for NHMRC support. Australian CIs may apply for up to $500,000 over a maximum of five years for each application. Holding an NHMRC-EU Collaborative Research Grant does not affect a CI’s ability to hold other NHMRC grants.

Only applicants who have their Administering Institution listed as an Associated Partner in a relevant EU application are eligible. Interested researchers should reach out to their European colleagues as soon as possible. The European application deadline for all the above opportunities is 12 April 2024.

Enquiries about the NHMRC-EU scheme or the Horizon Europe scheme may be directed to nhmrc@research.uq.edu.au.

Key Dates:

• GACD Application portal open: 11 February 2024
• Application due to UQ R&I: 17 April 2023
• Applications due to GACD (first stage): 15 May 2024, 6pm Central European Time
• First stage proposal outcomes: 23 August 2024
• Second stage application due to UQ R&I: 5 September 2024
• Second stage proposals due to GACD (By invitation only): 03 October 2024
• Applications due in Sapphire: 8 October 2024

The NHMRC is inviting Australian researchers to submit applications for the ninth Global Alliance for Chronic Diseases (GACD) funding call: ‘Management of Multiple Long-Term Conditions’ (MTLC).

This call will focus on implementation research that aims to improve the availability of effective, equitable, efficient, integrated, patient-centred, safe, and timely care for people living with multiple long-term conditions including non-communicable diseases (MLTC NCD, also known as NCD multimorbidity) in low- and middle-income countries (LMICs) and/or in disadvantaged populations in high-income countries (HICs).

For NHMRC funding support, the research must focus on Aboriginal and/or Torres Strait Islander communities.

The ninth GACD funding call will follow a two-step evaluation procedure.

Application Process:

1. Applicants inform the GACD secretariat by completing this short form: GACD Intention to apply
2. First stage applications must be submitted electronically to the GACD Common Submission Portal.
3. Shortlisted first stage applicants will be invited to electronically submit a second stage proposal to the GACD Portal.
4. Applicants must also submit a full application to NHMRC through Sapphire (currently not open yet).  

Further Information:

Please refer to the NHMRC-GACD 2024 Grant Guidelines on GrantConnect

The GACD guidelines and proposal template are available on the GACD website.

If you are interested in submitting an application for this scheme, please contact internationalgrants@research.uq.edu.au
 

UQ Documents

Mandatory Forms

• NHMRC GACD Certification form (DOCX, 72.6 KB)

Key Dates:

• GACD Application portal open: 3 July 2024
• Application due to UQ R&I: 19 August 2024
• Applications due to AMED: 28 August 2024 (5pm AEST)
• Applications due to NHMRC: 29 August 2024 (5pm AEST)
• Anticipated proposal outcomes: February 2025

NHMRC and Japan Agency for Medical Research and Development (AMED) are participating in a bilateral grant opportunity through AMED’s Adopting Sustainable Partnerships for an Innovative Research Ecosystem (ASPIRE) program. This grant opportunity is open to collaborative projects led by at least one Australia-based and one Japan-based investigator.

Adopting Sustainable Partnerships for Innovative Research Ecosystem (ASPIRE) aims to provide sufficient funds for up to three (3) large-scale collaborative joint research projects in cutting-edge fields, to elucidate the mechanisms underlying the maintenance and disruption of biological functions in complex systems.

Application Process

1. The Japanese Lead Investigator submits the Common Application to AMED by 28 August 2024 and the Australian Lead Investigator submits the same Common Application to NHMRC in Sapphire by 29 August 2024.
2. AMED & NHMRC conduct separate eligibility checks and peer review of submitted applications.
3. AMED & NHMRC submit their shortlist of eligible applications to the NHMRC-AMED Joint Funders Meeting.
4. The NHMRC-AMED Joint Funders Meeting compile a final ranking list and recommends projects for funding.
5. AMED & NHMRC approve funding recommendations.

Key Documents

NHMRC

NHMRC documentation, including Guidelines and the Common Application template, is available from GrantConnect (GO7043)

AMED

The AMED ASPIRE guidelines and Common Application template are available from the AMED ASPIRE website.

Further Information:

If you are interested in submitting an application for this scheme, please contact internationalgrants@research.uq.edu.au
 

UQ Documents

Mandatory Forms

• NHMRC-AMED ASPIRE Certification form (DOCX, 72.4 KB)

Key Dates:

• Estimated Period of Release: July to December 2024
• Application due to UQ RO: TBA
• Applications due to NHMRC/CIHR: TBA
• Anticipated proposal outcomes: TBA

NHMRC and the Canadian Institutes of Health Research (CIHR) are considering a bilateral call for a new phase of funding for the Canadian Consortium on Neurodegeneration in Aging (CCNA), which is funded by CIHR and partners. 

NHMRC will support Canadian-Australian collaborative teams undertaking research that advances the field of research in any of the recognised forms of dementia, specifically in Indigenous populations, focusing on either:  

• The development, implementation, evaluation and/or scaling of Indigenous-led, and/or culturally appropriate and Indigenous-grounded approaches to risk reduction, early detection, diagnosis and assessment of age-related neurodegenerative diseases; and/or 
• The development, implementation, evaluation and/or scaling of Indigenous-led, and/or culturally appropriate and Indigenous-grounded approaches to different models of care for age-related neurodegenerative diseases in Indigenous Peoples and communities.

CIHR is providing a Partner Linkage Tool that is intended to facilitate connections between researchers and knowledge users. This is not a mandatory tool. The table will be updated weekly until the application deadline. If you would like to use this tool, please complete a short survey. The information you provide will appear on a public CIHR web page. Please note that potential applicants are not required to use the linkage tool or contact those who have submitted their information.